201 related articles for article (PubMed ID: 23547051)
1. C/EBPα is required for development of dendritic cell progenitors.
Welner RS; Bararia D; Amabile G; Czibere A; Benoukraf T; Bach C; Wansa KD; Ye M; Zhang H; Iino T; Hetherington CJ; Akashi K; Tenen DG
Blood; 2013 May; 121(20):4073-81. PubMed ID: 23547051
[TBL] [Abstract][Full Text] [Related]
2. TNFα Rescues Dendritic Cell Development in Hematopoietic Stem and Progenitor Cells Lacking C/EBPα.
Anirudh S; Rosenberger A; Schwarzenberger E; Schaefer C; Strobl H; Zebisch A; Sill H; Wölfler A
Cells; 2020 May; 9(5):. PubMed ID: 32429067
[TBL] [Abstract][Full Text] [Related]
3. TGF-beta1 accelerates dendritic cell differentiation from common dendritic cell progenitors and directs subset specification toward conventional dendritic cells.
Felker P; Seré K; Lin Q; Becker C; Hristov M; Hieronymus T; Zenke M
J Immunol; 2010 Nov; 185(9):5326-35. PubMed ID: 20881193
[TBL] [Abstract][Full Text] [Related]
4. Induction of C/EBPalpha activity alters gene expression and differentiation of human CD34+ cells.
Cammenga J; Mulloy JC; Berguido FJ; MacGrogan D; Viale A; Nimer SD
Blood; 2003 Mar; 101(6):2206-14. PubMed ID: 12406909
[TBL] [Abstract][Full Text] [Related]
5. Lineage-instructive function of C/EBPα in multipotent hematopoietic cells and early thymic progenitors.
Wölfler A; Danen-van Oorschot AA; Haanstra JR; Valkhof M; Bodner C; Vroegindeweij E; van Strien P; Novak A; Cupedo T; Touw IP
Blood; 2010 Nov; 116(20):4116-25. PubMed ID: 20807890
[TBL] [Abstract][Full Text] [Related]
6. Antagonistic effect of CCAAT enhancer-binding protein-alpha and Pax5 in myeloid or lymphoid lineage choice in common lymphoid progenitors.
Hsu CL; King-Fleischman AG; Lai AY; Matsumoto Y; Weissman IL; Kondo M
Proc Natl Acad Sci U S A; 2006 Jan; 103(3):672-7. PubMed ID: 16407117
[TBL] [Abstract][Full Text] [Related]
7. Antagonistic regulation by the transcription factors C/EBPα and MITF specifies basophil and mast cell fates.
Qi X; Hong J; Chaves L; Zhuang Y; Chen Y; Wang D; Chabon J; Graham B; Ohmori K; Li Y; Huang H
Immunity; 2013 Jul; 39(1):97-110. PubMed ID: 23871207
[TBL] [Abstract][Full Text] [Related]
8. CCAAT/enhancer binding protein alpha uses distinct domains to prolong pituitary cells in the growth 1 and DNA synthesis phases of the cell cycle.
Liu W; Enwright JF; Hyun W; Day RN; Schaufele F
BMC Cell Biol; 2002 Mar; 3():6. PubMed ID: 11914124
[TBL] [Abstract][Full Text] [Related]
9. Comprehensive analysis of myeloid lineage conversion using mice expressing an inducible form of C/EBP alpha.
Fukuchi Y; Shibata F; Ito M; Goto-Koshino Y; Sotomaru Y; Ito M; Kitamura T; Nakajima H
EMBO J; 2006 Jul; 25(14):3398-410. PubMed ID: 16858416
[TBL] [Abstract][Full Text] [Related]
10. C/EBPalpha determines hematopoietic cell fate in multipotential progenitor cells by inhibiting erythroid differentiation and inducing myeloid differentiation.
Suh HC; Gooya J; Renn K; Friedman AD; Johnson PF; Keller JR
Blood; 2006 Jun; 107(11):4308-16. PubMed ID: 16469877
[TBL] [Abstract][Full Text] [Related]
11. EVI2B is a C/EBPα target gene required for granulocytic differentiation and functionality of hematopoietic progenitors.
Zjablovskaja P; Kardosova M; Danek P; Angelisova P; Benoukraf T; Wurm AA; Kalina T; Sian S; Balastik M; Delwel R; Brdicka T; Tenen DG; Behre G; Fiore F; Malissen B; Horejsi V; Alberich-Jorda M
Cell Death Differ; 2017 Apr; 24(4):705-716. PubMed ID: 28186500
[TBL] [Abstract][Full Text] [Related]
12. Transcription activation function of C/EBPalpha is required for induction of granulocytic differentiation.
Keeshan K; Santilli G; Corradini F; Perrotti D; Calabretta B
Blood; 2003 Aug; 102(4):1267-75. PubMed ID: 12702500
[TBL] [Abstract][Full Text] [Related]
13. C/EBPα is required for long-term self-renewal and lineage priming of hematopoietic stem cells and for the maintenance of epigenetic configurations in multipotent progenitors.
Hasemann MS; Lauridsen FK; Waage J; Jakobsen JS; Frank AK; Schuster MB; Rapin N; Bagger FO; Hoppe PS; Schroeder T; Porse BT
PLoS Genet; 2014 Jan; 10(1):e1004079. PubMed ID: 24415956
[TBL] [Abstract][Full Text] [Related]
14. C/EBPalpha deficiency results in hyperproliferation of hematopoietic progenitor cells and disrupts macrophage development in vitro and in vivo.
Heath V; Suh HC; Holman M; Renn K; Gooya JM; Parkin S; Klarmann KD; Ortiz M; Johnson P; Keller J
Blood; 2004 Sep; 104(6):1639-47. PubMed ID: 15073037
[TBL] [Abstract][Full Text] [Related]
15. Origin and development of dendritic cells.
Liu K; Nussenzweig MC
Immunol Rev; 2010 Mar; 234(1):45-54. PubMed ID: 20193011
[TBL] [Abstract][Full Text] [Related]
16. Multipotent hematopoietic cell lines derived from C/EBPalpha(-/-) knockout mice display granulocyte macrophage-colony-stimulating factor, granulocyte- colony-stimulating factor, and retinoic acid-induced granulocytic differentiation.
Collins SJ; Ulmer J; Purton LE; Darlington G
Blood; 2001 Oct; 98(8):2382-8. PubMed ID: 11588034
[TBL] [Abstract][Full Text] [Related]
17. Tissue-specific differentiation of a circulating CCR9- pDC-like common dendritic cell precursor.
Schlitzer A; Heiseke AF; Einwächter H; Reindl W; Schiemann M; Manta CP; See P; Niess JH; Suter T; Ginhoux F; Krug AB
Blood; 2012 Jun; 119(25):6063-71. PubMed ID: 22547585
[TBL] [Abstract][Full Text] [Related]
18. Absence of the transcription factor CCAAT enhancer binding protein alpha results in loss of myeloid identity in bcr/abl-induced malignancy.
Wagner K; Zhang P; Rosenbauer F; Drescher B; Kobayashi S; Radomska HS; Kutok JL; Gilliland DG; Krauter J; Tenen DG
Proc Natl Acad Sci U S A; 2006 Apr; 103(16):6338-43. PubMed ID: 16606850
[TBL] [Abstract][Full Text] [Related]
19. CpG methylation of half-CRE sequences creates C/EBPalpha binding sites that activate some tissue-specific genes.
Rishi V; Bhattacharya P; Chatterjee R; Rozenberg J; Zhao J; Glass K; Fitzgerald P; Vinson C
Proc Natl Acad Sci U S A; 2010 Nov; 107(47):20311-6. PubMed ID: 21059933
[TBL] [Abstract][Full Text] [Related]
20. NF-kappa B p50 regulates C/EBP alpha expression and inflammatory cytokine-induced neutrophil production.
Wang D; Paz-Priel I; Friedman AD
J Immunol; 2009 May; 182(9):5757-62. PubMed ID: 19380823
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
